RLAY Sale Disclosure
Catinazzo Thomas · SEC Form 4 · Filed Oct 8, 2026
Sale
Calculated transaction value
$325.35K
Catinazzo Thomas Chief Financial Officer
RLAY
Relay Therapeutics
RLAY
Transaction date
Oct 6, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 2 days later
RLAY daily price context
Close on/before transaction
$18.74
Oct 6, 2026
First close after public filing
$17.84
Oct 9, 2026
Return after filing · so far
0.0%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 17,511 shares @ $18.58
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-418094
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$329.32K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Relay Therapeutics, Inc. RLAY Current | Sale | Oct 6, 2026 | $325.35K |
| Relay Therapeutics, Inc. RLAY | Sale | Oct 6, 2026 | $3.97K |